OpenAI Blog
Sep 12, 2024
Decoding genetics with OpenAI o1
Geneticist Catherine Brownstein demonstrates how OpenAI o1 can speed up the process of diagnosing rare medical challenges.
Finding the molecular switches behind new infectious diseases
Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
Related stories
OpenAI Blog
Jun 18
Using AI to help physicians diagnose rare genetic diseases affecting children
Researchers used an OpenAI reasoning model to help diagnose rare diseases, identifying 18 new diagnoses in previously unsolved cases.
DeepMind Blog
Jun 25, 2025
AlphaGenome: AI for better understanding the genome
Introducing a new, unifying DNA sequence model that advances regulatory variant-effect prediction and promises to shed new light on genome function — now available via API.
OpenAI Blog
Apr 16
Introducing GPT-Rosalind for life sciences research
OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
OpenAI Blog
Jan 31, 2024
Building an early warning system for LLM-aided biological threat creation
We’re developing a blueprint for evaluating the risk that a large language model (LLM) could aid someone in creating a biological threat. In an evaluation involving both biology experts and students, we found that GPT-4 provides at most a mild uplift in biological threat creation accuracy.
DeepMind Blog
May 16
Uncovering repurposed medicines to fight liver fibrosis
Stanford geneticist uses Co-Scientist to help find new treatments for chronic liver disease and liver fibrosis.
arXiv AI
Aug 10
Artificial Intelligence Can Match Domain Experts in Evidence Extraction and Critical Appraisal of Microbial Oncogenesis Research Publications
arXiv:2608. 07250v1 Announce Type: cross Abstract: Confirmed oncogenic microbes contribute significantly to cancer burden.
arXiv AI
Aug 10
Genotypic Triggers: Exposing Pharmacogenomic Blind Spots via Host-Specific Backdoors in Generative Antimicrobial Peptide Models
arXiv:2608. 06779v1 Announce Type: cross Abstract: Large Language Models (LLMs) have accelerated drug discovery, particularly in the automated design of antimicrobial peptides (AMPs).
arXiv AI
Jun 30
Accelerating scientific discovery with Co-Scientist
arXiv:2502. 18864v2 Announce Type: replace Abstract: Scientific discovery is driven by scientists generating novel hypotheses for complex problems that undergo rigorous experimental validation.
OpenAI Blog
Jun 23
How GPT-5 helped immunologist Derya Unutmaz solve a 3-year-old mystery
GPT-5 Pro helped solve a 3-year-old immunology mystery, offering insights into T cell behavior. The breakthrough could support cancer and autoimmune research.
arXiv AI
Jul 7
Leveraging Natural Language Processing to Unravel the Mystery of Life: A Review of NLP Approaches in Genomics, Transcriptomics, and Proteomics
arXiv:2506. 02212v2 Announce Type: replace-cross Abstract: Natural Language Processing (NLP) has transformed various fields beyond linguistics by applying techniques originally developed for human language to the analysis of biological sequences.
DeepMind Blog
May 16
Accelerating discovery of liver disease mechanisms
Filippo Menolascina uses Co-Scientist to identify new liver disease treatments and explain why existing drugs only help certain patients.